Margaret L. Griffin mostly deals with Psychiatry, Substance abuse, Randomized controlled trial, Cocaine dependence and Clinical psychology. Her research on Psychiatry frequently links to adjacent areas such as Internal medicine. Her research integrates issues of Psychopathology, Mood, Cognitive therapy, Addiction and Drug in her study of Substance abuse.
Her studies examine the connections between Randomized controlled trial and genetics, as well as such issues in Clinical trial, with regards to Medical prescription and Anesthesia. Margaret L. Griffin combines subjects such as Treatment outcome and Craving with her study of Cocaine dependence. Her work deals with themes such as Abstinence and Cyclothymic Disorder, which intersect with Clinical psychology.
Margaret L. Griffin spends much of her time researching Psychiatry, Substance abuse, Clinical psychology, Bipolar disorder and Opioid use disorder. Her biological study spans a wide range of topics, including Young adult and Randomized controlled trial. Her Substance abuse research incorporates themes from Internal medicine, Clinical trial, Cocaine dependence, Addiction and Attendance.
In general Internal medicine, her work in Severity of illness is often linked to Buprenorphine, Opiate Substitution Treatment and Naloxone linking many areas of study. She works mostly in the field of Clinical psychology, limiting it down to concerns involving Craving and, occasionally, Predictive validity. Her Bipolar disorder research integrates issues from Group psychotherapy, Dual diagnosis, Substance dependence and Comorbidity.
Margaret L. Griffin mostly deals with Psychiatry, Opioid use disorder, Substance abuse, Heroin and Clinical psychology. Her work carried out in the field of Psychiatry brings together such families of science as Young adult and Medical prescription. Her Young adult study incorporates themes from Randomized controlled trial and Chronic pain.
Her Substance abuse study integrates concerns from other disciplines, such as Psychological intervention and Internal medicine. Her Heroin research includes a combination of various areas of study, such as Buprenorphine and Prescription opioid. As a part of the same scientific family, Margaret L. Griffin mostly works in the field of Clinical psychology, focusing on Craving and, on occasion, Predictive validity.
Her primary scientific interests are in Psychiatry, Young adult, Chronic pain, Opioid-Related Disorders and Heroin. Her studies in Psychiatry integrate themes in fields like Clinical trial and Clinical psychology. In her work, Severity of illness and Physical therapy is strongly intertwined with Addiction, which is a subfield of Young adult.
In her study, which falls under the umbrella issue of Chronic pain, Gerontology and Quality of life is strongly linked to Medical prescription. Her work in Heroin is not limited to one particular discipline; it also encompasses Substance abuse. Margaret L. Griffin performs multidisciplinary study in Substance abuse and Alcohol use disorder in her work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study.
Paul Crits-Christoph;Lynne Siqueland;Jack Blaine;Arlene Frank.
Archives of General Psychiatry (1999)
A comparison of male and female cocaine abusers.
Margaret L. Griffin;Roger D. Weiss;Steven M. Mirin;Ulrike Lange.
Archives of General Psychiatry (1989)
Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence A 2-Phase Randomized Controlled Trial
Roger D. Weiss;Jennifer Sharpe Potter;David A. Fiellin;David A. Fiellin;Marilyn Byrne;Marilyn Byrne.
Archives of General Psychiatry (2011)
Alterations in brain structure and functional connectivity in prescription opioid-dependent patients
Jaymin Upadhyay;Nasim Maleki;Jennifer Sharpe Potter;Jennifer Sharpe Potter;Igor Elman.
Brain (2010)
Drug abuse as self-medication for depression: an empirical study.
Roger D. Weiss;Margaret L. Griffin;Steven M. Mirin.
American Journal of Drug and Alcohol Abuse (1992)
A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence
Roger D. Weiss;Margaret L. Griffin;Monika E. Kolodziej;M.P.H. Shelly F. Greenfield.
American Journal of Psychiatry (2007)
Psychopathology in cocaine abusers: Changing trends.
Roger D. Weiss;Steven M. Mirin;Margaret L. Griffin;Jacqueline L. Michael.
Journal of Nervous and Mental Disease (1988)
Psychopathology in drug abusers and their families.
Steven M. Mirin;Roger D. Weiss;Roger D. Weiss;Margaret L. Griffin;Margaret L. Griffin;Jacqueline L. Michael;Jacqueline L. Michael.
Comprehensive Psychiatry (1991)
Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study.
Roger D. Weiss;Margaret L. Griffin;Shelly F. Greenfield;Lisa M. Najavits.
The Journal of Clinical Psychiatry (2000)
Medication Compliance Among Patients With Bipolar Disorder and Substance Use Disorder
Roger D. Weiss;Shelly F. Greenfield;Lisa M. Najavits;Jose A. Soto.
The Journal of Clinical Psychiatry (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
Harvard University
Harvard University
Boston University
Harvard University
University of Pennsylvania
Adelphi University
West Chester University
University of Pennsylvania
University of Pennsylvania
Idiap Research Institute
Tel Aviv University
Yale University
University of Würzburg
National Institutes of Health
Tokyo Institute of Technology
Massey University
Agricultural Research Service
Spanish National Research Council
Iowa State University
Harvard University
Children's Hospital of Philadelphia
Vanderbilt University
Scripps Research Institute
Baylor University Medical Center
University of Tokyo